| Name | Title | Contact Details |
|---|
Accredo Health Group, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
The new Actavis, Inc. (NYSE:ACT) is a combination of the previously separate Watson Pharmaceuticals, Inc. and Swiss-based Actavis Group. Actavis, Inc. is a specialty pharmaceutical company that develops, manufactures and distributes generic, brand and biosimilar products. The Company has global headquarters in Parsippany, NJ and international headquarters in Zug, Switzerland.
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Like everything from Combe, this family of Brimms products is famous for quality. These products reflect the exceptionally high standards Combe holds to provide customers with complete satisfaction.
MAQUET offers complete medical technology solutions for operating theatres and intensive care units, guaranteeing optimum treatment for patients and greatest-possible working comfort for personnel. MAQUET - The Gold Standard. To enter the MAQUET website